←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy and ctDNA, Colorectal
Scott Kopetz
MD, PhD
🏢MD Anderson Cancer Center🌐USA
Professor, Associate VP for Translational Integration
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Scott Kopetz led the BEACON trial establishing encorafenib plus cetuximab for BRAF V600E metastatic colorectal cancer. He is associate VP for translational integration at MD Anderson and a leader in ctDNA MRD and perioperative CRC trial design. His work shapes precision perioperative therapy in CRC.
Share:
🧪Research Fields 研究领域
BEACON CRC
BRAF CRC
ctDNA MRD
CRC precision oncology
perioperative trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Scott Kopetz 的研究动态
Follow Scott Kopetz's research updates
留下邮箱，当我们发布与 Scott Kopetz（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment